Ninatti, Gaia; Scilipoti, Pietro; Pini, Cristiano; Barletta, Francesco; Longoni, Mattia; Gelardi, Fabrizia; Sollini, Martina; Gandaglia, Giorgio; Sathekge, Mike Machaba; Montorsi, Francesco; Chiti, Arturo; Briganti, Alberto
(Ivyspring International Publisher, 2025-02)
RATIONALE : Metastatic prostate cancer in the castration-resistant (mCRPC) setting remains challenging to treat. Prostate-specific membrane antigen (PSMA)-targeted alpha therapy (TAT) is emerging as a promising option. We ...